Harris Cynthia K, Darrell Caitlin M, VanderLaan Paul A, Heher Yael K
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Department of Pathology, Advocate Health Care, Oak Lawn, Illinois, USA.
Cancer Cytopathol. 2023 Jan;131(1):10-18. doi: 10.1002/cncy.22627. Epub 2022 Jul 29.
Medical errors are a major source of harm to patients. Regulatory bodies mandate and patient safety experts advocate the disclosure of medical errors to patients to promote transparency and to create accountability for improving health care processes. Although pathologists regularly report errors-either to pathology or clinical colleagues or via internal safety reporting systems-few pathologists directly disclose those errors to patients. Yet many pathologists are interested in participating in the direct disclosure of medical errors to patients and may even be mandated to do so. When surveyed on why they do not directly disclose errors to patients, pathologists commonly cite a lack of confidence and a lack of training. Another barrier cited is the lack of a preexisting relationship between the pathologist and the patient. With respect to this last barrier, cytopathologists have a distinct advantage over surgical or clinical pathologists, as many cytopathologists regularly interact with and develop a rapport with patients when they are performing fine-needle aspiration (FNA) procedures. To improve the safety culture in pathology, direct error disclosure practices must be developed, supported, and strengthened. It is critical for cytopathologists to be comfortable with disclosing errors to patients. Being comfortable with disclosing an error, however, requires training, practice, and advance reflection. Using a practical, case-based format centered around FNA examples, this article addresses how to disclose a medical error to a patient. It provides a framework, heuristic principles, and structured conversation systems and talking points to guide the inexperienced pathologist to find his or her voice in a challenging disclosure conversation.
医疗差错是患者伤害的主要来源。监管机构强制要求,患者安全专家也提倡向患者披露医疗差错,以提高透明度,并为改善医疗保健流程建立问责制。尽管病理学家经常向病理科或临床同事报告差错,或通过内部安全报告系统报告,但很少有病理学家直接向患者披露这些差错。然而,许多病理学家有兴趣直接向患者披露医疗差错,甚至可能被要求这样做。当被问及为何不直接向患者披露差错时,病理学家通常会提到缺乏信心和缺乏培训。另一个被提及的障碍是病理学家与患者之间缺乏既存关系。关于这最后一个障碍,细胞病理学家相对于外科或临床病理学家有明显优势,因为许多细胞病理学家在进行细针穿刺(FNA)操作时经常与患者互动并建立融洽关系。为了改善病理领域的安全文化,必须制定、支持并加强直接差错披露做法。细胞病理学家能够自如地向患者披露差错至关重要。然而,要能够自如地披露差错,需要培训、实践和预先思考。本文采用以FNA实例为中心的实用案例形式,阐述了如何向患者披露医疗差错。它提供了一个框架、启发式原则、结构化对话系统和谈话要点,以指导缺乏经验的病理学家在具有挑战性的披露对话中找到自己的表达方式。